Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Naresh Mandava

Concepts (373)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Macular Degeneration
21
2023
159
4.870
 Why?
Geographic Atrophy
10
2025
69
3.240
 Why?
Visual Acuity
20
2024
321
2.250
 Why?
Retinal Detachment
6
2023
56
2.060
 Why?
Wet Macular Degeneration
7
2025
46
2.000
 Why?
Fluorescein Angiography
18
2025
143
1.970
 Why?
Diabetic Retinopathy
11
2023
177
1.880
 Why?
Retinal Drusen
4
2024
31
1.800
 Why?
Tomography, Optical Coherence
13
2025
186
1.760
 Why?
Angiogenesis Inhibitors
17
2023
220
1.730
 Why?
Registries
8
2025
1895
1.640
 Why?
Vitreous Body
16
2022
109
1.160
 Why?
Vitrectomy
12
2020
64
1.090
 Why?
Multimodal Imaging
2
2025
110
1.050
 Why?
Macula Lutea
2
2023
21
1.020
 Why?
Retina
10
2021
277
0.900
 Why?
Vascular Endothelial Growth Factor A
12
2023
530
0.830
 Why?
Retinal Diseases
4
2023
86
0.820
 Why?
Antibodies, Monoclonal
9
2011
1367
0.810
 Why?
Retinal Neovascularization
2
2019
25
0.750
 Why?
Choroidal Neovascularization
6
2019
55
0.730
 Why?
National Eye Institute (U.S.)
1
2020
6
0.710
 Why?
Retinal Perforations
4
2015
13
0.700
 Why?
Quarantine
1
2020
27
0.680
 Why?
Biomarkers
7
2025
3966
0.670
 Why?
Aged, 80 and over
18
2025
7055
0.660
 Why?
Choroid
6
2024
62
0.630
 Why?
Retinopathy of Prematurity
4
2024
141
0.610
 Why?
Estrogen Replacement Therapy
1
2019
137
0.610
 Why?
Retinitis Pigmentosa
3
2021
20
0.590
 Why?
Aged
30
2025
22032
0.570
 Why?
Follow-Up Studies
15
2025
4886
0.550
 Why?
Intraocular Pressure
6
2012
297
0.530
 Why?
Epiretinal Membrane
3
2010
7
0.530
 Why?
Automobile Driving
1
2018
140
0.520
 Why?
Scleral Buckling
3
2019
18
0.490
 Why?
Proliferating Cell Nuclear Antigen
2
2007
53
0.480
 Why?
Vitreoretinopathy, Proliferative
2
2007
12
0.480
 Why?
Humans
80
2025
129248
0.480
 Why?
Female
50
2025
68543
0.460
 Why?
Optic Neuropathy, Ischemic
3
2013
30
0.450
 Why?
Self Report
1
2018
795
0.450
 Why?
RNA, Catalytic
2
2007
185
0.450
 Why?
Antibodies, Monoclonal, Humanized
11
2015
758
0.450
 Why?
Male
48
2025
63501
0.440
 Why?
Recombinant Fusion Proteins
4
2013
648
0.430
 Why?
Prospective Studies
9
2025
7121
0.430
 Why?
Middle Aged
31
2025
31087
0.410
 Why?
Research Design
1
2019
1043
0.400
 Why?
Surveys and Questionnaires
4
2022
5382
0.400
 Why?
Bevacizumab
11
2015
129
0.400
 Why?
Fundus Oculi
5
2025
61
0.390
 Why?
Retinal Necrosis Syndrome, Acute
2
2013
8
0.380
 Why?
Pandemics
1
2020
1482
0.380
 Why?
Retinal Vein Occlusion
2
2015
13
0.380
 Why?
Photography
4
2015
93
0.380
 Why?
Endophthalmitis
3
2017
28
0.370
 Why?
Uveal Diseases
2
2013
5
0.360
 Why?
Colorado
8
2025
4406
0.360
 Why?
Cataract
2
2020
208
0.350
 Why?
Diagnostic Techniques, Ophthalmological
2
2015
38
0.340
 Why?
Complement Factor B
2
2022
108
0.330
 Why?
Visual Fields
3
2022
87
0.330
 Why?
Glycogen Storage Disease Type IIb
2
2007
25
0.330
 Why?
Retrospective Studies
24
2024
14455
0.320
 Why?
Vision, Low
4
2022
16
0.320
 Why?
Pigment Epithelium of Eye
2
2006
35
0.310
 Why?
Retinal Pigment Epithelium
2
2024
70
0.310
 Why?
Injections
6
2010
174
0.310
 Why?
Complement Activation
3
2022
381
0.300
 Why?
Ophthalmology
2
2013
82
0.300
 Why?
Health Knowledge, Attitudes, Practice
2
2014
1276
0.300
 Why?
Ocular Hypertension
1
2009
66
0.290
 Why?
Phacoemulsification
3
2020
115
0.280
 Why?
Optic Nerve Injuries
1
2007
4
0.280
 Why?
Macular Edema
2
2015
43
0.280
 Why?
Quantum Dots
2
2021
34
0.280
 Why?
Encephalitis, Herpes Simplex
1
2007
21
0.280
 Why?
Vision Disorders
2
2022
135
0.270
 Why?
von Hippel-Lindau Disease
1
2007
12
0.270
 Why?
Papilledema
1
2007
39
0.270
 Why?
Fovea Centralis
2
2010
11
0.270
 Why?
Puerperal Disorders
1
2007
30
0.270
 Why?
Glucocorticoids
2
2013
578
0.260
 Why?
Triamcinolone Acetonide
1
2006
27
0.260
 Why?
Ocular Hypotension
1
2006
10
0.260
 Why?
Herpesvirus 1, Human
1
2007
86
0.250
 Why?
Ciliary Body
1
2006
33
0.250
 Why?
Myopia
1
2006
47
0.250
 Why?
Telangiectasis
1
2005
6
0.250
 Why?
Granuloma
1
2006
89
0.240
 Why?
Chemokine CCL5
2
2023
43
0.240
 Why?
DNA, Viral
1
2007
349
0.240
 Why?
Retinal Vessels
1
2005
65
0.230
 Why?
Retinal Ganglion Cells
4
2022
98
0.230
 Why?
Diabetes Mellitus
2
2023
1000
0.220
 Why?
Laser Therapy
2
2021
129
0.220
 Why?
Disease Progression
5
2025
2630
0.220
 Why?
Fluorocarbons
1
2005
109
0.220
 Why?
Vision Tests
1
2023
16
0.220
 Why?
Birth Weight
2
2024
505
0.220
 Why?
Diseases in Twins
1
2024
175
0.210
 Why?
Temporal Arteries
2
2015
45
0.210
 Why?
Risk Factors
10
2024
9745
0.210
 Why?
Twins
1
2024
249
0.210
 Why?
Receptors, Vascular Endothelial Growth Factor
3
2013
107
0.210
 Why?
Hemianopsia
1
2022
9
0.200
 Why?
Cross-Sectional Studies
5
2024
5045
0.200
 Why?
Disease Models, Animal
4
2012
4057
0.200
 Why?
Optic Disk
3
2010
40
0.190
 Why?
Ophthalmoscopy
2
2015
35
0.190
 Why?
Posterior Capsulotomy
1
2021
7
0.190
 Why?
Posterior Capsule of the Lens
1
2021
11
0.180
 Why?
Capsule Opacification
1
2021
22
0.180
 Why?
Lasers, Solid-State
1
2021
22
0.180
 Why?
Complement System Proteins
2
2022
317
0.180
 Why?
Ranibizumab
5
2013
20
0.180
 Why?
Sickness Impact Profile
1
2020
55
0.180
 Why?
Posterior Capsular Rupture, Ocular
1
2020
6
0.170
 Why?
Neurodegenerative Diseases
1
2022
112
0.170
 Why?
Herpesvirus 3, Human
2
2015
331
0.170
 Why?
Nerve Fibers
2
2010
89
0.170
 Why?
Electrodes, Implanted
2
2018
106
0.160
 Why?
Intravitreal Injections
6
2020
56
0.160
 Why?
Protective Factors
1
2019
91
0.160
 Why?
Odds Ratio
2
2019
1018
0.160
 Why?
Ischemia
2
2017
406
0.160
 Why?
Intraoperative Complications
1
2020
129
0.160
 Why?
Complement Membrane Attack Complex
1
2019
37
0.160
 Why?
Complement C3a
1
2019
41
0.160
 Why?
C-Reactive Protein
1
2021
400
0.160
 Why?
Visual Prosthesis
1
2018
1
0.150
 Why?
Cohort Studies
5
2020
5408
0.150
 Why?
Postoperative Complications
3
2021
2473
0.140
 Why?
Quality of Life
4
2022
2685
0.140
 Why?
Orbit
2
2010
57
0.140
 Why?
Metformin
1
2021
315
0.140
 Why?
Anterior Eye Segment
1
2017
9
0.140
 Why?
Reproducibility of Results
2
2023
3079
0.140
 Why?
Gestational Age
4
2024
874
0.140
 Why?
Fetal Membranes, Premature Rupture
1
2017
36
0.140
 Why?
Labor, Induced
1
2017
30
0.140
 Why?
Strabismus
1
2017
28
0.130
 Why?
Laser Coagulation
3
2012
57
0.130
 Why?
Labor, Obstetric
1
2017
58
0.130
 Why?
Time Factors
4
2021
6543
0.130
 Why?
Giant Cell Arteritis
2
2015
49
0.130
 Why?
Ophthalmologic Surgical Procedures
1
2017
57
0.130
 Why?
Retinal Degeneration
2
2015
34
0.130
 Why?
Blindness
3
2013
38
0.120
 Why?
Recovery of Function
1
2019
641
0.120
 Why?
Gyrate Atrophy
1
2015
2
0.120
 Why?
Phenotype
3
2022
3074
0.120
 Why?
Case-Control Studies
2
2020
3377
0.120
 Why?
Incidence
2
2020
2636
0.120
 Why?
Vitreoretinal Surgery
1
2015
3
0.120
 Why?
Eye Infections, Bacterial
1
2015
27
0.120
 Why?
Multivariate Analysis
1
2019
1497
0.120
 Why?
Immunosuppressive Agents
2
2013
854
0.120
 Why?
Vitreous Detachment
1
2015
9
0.120
 Why?
Needles
1
2015
57
0.120
 Why?
Encephalitis, Varicella Zoster
1
2015
17
0.120
 Why?
Biopsy, Needle
1
2015
189
0.120
 Why?
Treatment Outcome
7
2021
10199
0.120
 Why?
Oculomotor Muscles
1
2014
38
0.120
 Why?
Wounds, Gunshot
2
2010
213
0.120
 Why?
Antiviral Agents
2
2013
712
0.120
 Why?
Proteins
1
2020
941
0.110
 Why?
Inflammation
3
2023
2737
0.110
 Why?
Logistic Models
1
2019
1984
0.110
 Why?
Rats, Inbred BN
3
2011
59
0.110
 Why?
Fibrin
1
2014
68
0.110
 Why?
Anti-Inflammatory Agents
2
2021
480
0.110
 Why?
Proteomics
1
2020
1054
0.110
 Why?
Exchange Transfusion, Whole Blood
1
2013
14
0.110
 Why?
Uvea
1
2013
1
0.110
 Why?
Uveomeningoencephalitic Syndrome
1
2013
7
0.110
 Why?
Drug Packaging
2
2011
41
0.110
 Why?
Retinal Artery Occlusion
1
2013
8
0.110
 Why?
Tendons
1
2014
106
0.110
 Why?
Drug Resistance, Multiple, Viral
1
2013
11
0.110
 Why?
Premature Birth
1
2017
314
0.110
 Why?
Cytomegalovirus Retinitis
1
2013
18
0.110
 Why?
Adult
15
2020
35495
0.100
 Why?
Isoxazoles
1
2013
55
0.100
 Why?
Lymphoproliferative Disorders
1
2013
54
0.100
 Why?
Silicon
1
2012
14
0.100
 Why?
Fatty Acids, Omega-3
1
2014
138
0.100
 Why?
Lens Subluxation
1
2012
3
0.100
 Why?
Viremia
1
2013
131
0.100
 Why?
Trabecular Meshwork
1
2013
79
0.100
 Why?
Exanthema
1
2013
74
0.100
 Why?
Uveitis, Posterior
1
2012
12
0.100
 Why?
Diagnostic Imaging
1
2015
327
0.100
 Why?
Fluocinolone Acetonide
1
2012
19
0.090
 Why?
Diagnosis, Differential
4
2013
1430
0.090
 Why?
Microsurgery
1
2012
70
0.090
 Why?
Placenta
1
2018
723
0.090
 Why?
Electric Stimulation Therapy
1
2012
77
0.090
 Why?
Particulate Matter
2
2011
246
0.090
 Why?
Vascular Endothelial Growth Factors
1
2011
78
0.090
 Why?
Global Health
1
2014
327
0.090
 Why?
Fluorescein-5-isothiocyanate
2
2009
37
0.090
 Why?
Electroretinography
2
2012
45
0.090
 Why?
Silicone Oils
1
2011
26
0.090
 Why?
Health Care Costs
1
2014
367
0.090
 Why?
Drug Storage
1
2011
57
0.090
 Why?
Dextrans
2
2009
83
0.090
 Why?
Glaucoma
2
2010
219
0.090
 Why?
Dissection
1
2011
51
0.090
 Why?
Antioxidants
1
2014
558
0.080
 Why?
Infliximab
2
2007
100
0.080
 Why?
Lysosomal-Associated Membrane Protein 2
2
2007
28
0.080
 Why?
Protein Multimerization
1
2011
178
0.080
 Why?
Anemia, Sickle Cell
1
2013
252
0.080
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
430
0.080
 Why?
Clinical Trials, Phase II as Topic
1
2009
72
0.080
 Why?
Clinical Trials, Phase I as Topic
1
2009
50
0.080
 Why?
United States
3
2020
13828
0.080
 Why?
Tonometry, Ocular
1
2009
88
0.080
 Why?
Bacteria
1
2015
812
0.080
 Why?
Herpes Zoster
1
2013
317
0.080
 Why?
Rats
4
2012
5482
0.070
 Why?
Scotoma
1
2008
5
0.070
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2009
252
0.070
 Why?
Retinal Artery
1
2007
16
0.070
 Why?
RNA, Messenger
2
2007
2703
0.070
 Why?
Vitreous Hemorrhage
1
2007
5
0.070
 Why?
Cerebral Angiography
1
2007
108
0.070
 Why?
Acyclovir
1
2007
99
0.070
 Why?
Dose-Response Relationship, Drug
2
2009
2008
0.070
 Why?
Frameshift Mutation
1
2006
32
0.060
 Why?
Ultrasonography
2
2007
713
0.060
 Why?
Secondary Prevention
1
2007
218
0.060
 Why?
Animals
7
2014
35307
0.060
 Why?
Conjunctival Neoplasms
1
2005
7
0.060
 Why?
Indocyanine Green
1
2005
19
0.060
 Why?
Internationality
2
2018
149
0.060
 Why?
Eye Injuries, Penetrating
1
2005
16
0.060
 Why?
Coloring Agents
1
2005
77
0.060
 Why?
Eye Foreign Bodies
1
2005
23
0.060
 Why?
Infant, Newborn
3
2024
5736
0.060
 Why?
beta-Thalassemia
1
2006
37
0.060
 Why?
Eye Injuries
1
2006
46
0.060
 Why?
Staining and Labeling
1
2005
141
0.060
 Why?
Tumor Necrosis Factor-alpha
2
2007
1202
0.060
 Why?
Uveitis
1
2006
127
0.060
 Why?
Antihypertensive Agents
1
2009
485
0.060
 Why?
Metals
1
2005
123
0.060
 Why?
Pregnancy
3
2018
6391
0.060
 Why?
Mydriatics
1
2004
3
0.060
 Why?
Pupil
1
2004
13
0.060
 Why?
Polymerase Chain Reaction
1
2007
1036
0.060
 Why?
Sclera
2
2014
36
0.050
 Why?
Hospitals, County
1
2023
10
0.050
 Why?
Sensitivity and Specificity
2
2008
1837
0.050
 Why?
Observer Variation
1
2004
315
0.050
 Why?
Fibroblasts
2
2013
947
0.050
 Why?
Cardiomyopathy, Dilated
1
2007
381
0.050
 Why?
Young Adult
6
2019
12388
0.050
 Why?
Enzyme-Linked Immunosorbent Assay
2
2019
833
0.050
 Why?
Double-Blind Method
1
2007
1875
0.050
 Why?
Chimera
1
2002
59
0.050
 Why?
Autoimmune Diseases
1
2006
426
0.050
 Why?
Enzyme Stability
1
2002
69
0.050
 Why?
Interleukin-4
1
2023
212
0.050
 Why?
Complement Factor I
1
2022
12
0.050
 Why?
Endopeptidases
1
2002
86
0.050
 Why?
Preventive Medicine
1
2002
41
0.050
 Why?
Aqueous Humor
1
2022
33
0.050
 Why?
Blood
1
2002
105
0.050
 Why?
Coculture Techniques
1
2002
223
0.050
 Why?
Albumins
1
2022
103
0.050
 Why?
Retreatment
2
2012
70
0.050
 Why?
Fibrinogen
1
2022
163
0.050
 Why?
Rabbits
1
2002
777
0.040
 Why?
Lenses, Intraocular
1
2021
43
0.040
 Why?
Cells, Cultured
2
2013
4076
0.040
 Why?
Cell Division
1
2002
796
0.040
 Why?
Drug Compounding
2
2011
97
0.040
 Why?
Equipment Design
2
2014
513
0.040
 Why?
Electric Stimulation
1
2021
269
0.040
 Why?
Immunologic Factors
1
2022
230
0.040
 Why?
Chronic Disease
1
2006
1715
0.040
 Why?
Cell Survival
2
2013
1074
0.040
 Why?
Melanoma
1
2005
729
0.040
 Why?
Lipids
1
2002
625
0.040
 Why?
Postoperative Period
1
2019
329
0.040
 Why?
Immunity, Maternally-Acquired
1
2018
18
0.040
 Why?
Infant
3
2020
8975
0.040
 Why?
Prevalence
2
2015
2554
0.040
 Why?
Combined Modality Therapy
2
2013
1199
0.040
 Why?
Primary Health Care
1
2008
1678
0.040
 Why?
Longitudinal Studies
1
2025
2716
0.040
 Why?
Iris Diseases
1
2017
6
0.030
 Why?
Choroid Diseases
1
2017
10
0.030
 Why?
Referral and Consultation
1
2022
727
0.030
 Why?
Prosthesis Implantation
1
2018
143
0.030
 Why?
Parity
1
2017
120
0.030
 Why?
Sex Characteristics
1
2022
736
0.030
 Why?
Infant, Low Birth Weight
1
2017
135
0.030
 Why?
Mental Health
1
2022
685
0.030
 Why?
Risk
1
2018
854
0.030
 Why?
Microbiological Techniques
1
2015
30
0.030
 Why?
Endotamponade
1
2015
2
0.030
 Why?
Colony Count, Microbial
1
2015
117
0.030
 Why?
Myopia, Degenerative
1
2015
4
0.030
 Why?
Tenon Capsule
1
2014
3
0.030
 Why?
Tissue Adhesions
1
2015
30
0.030
 Why?
Cerebral Arterial Diseases
1
2015
48
0.030
 Why?
Adolescent
3
2012
20303
0.030
 Why?
Atrophy
1
2015
171
0.030
 Why?
Conjunctiva
1
2014
51
0.030
 Why?
Biometry
1
2014
69
0.030
 Why?
Lens Implantation, Intraocular
1
2015
59
0.030
 Why?
Fetus
1
2018
770
0.030
 Why?
T-Lymphocytes
1
2022
1933
0.030
 Why?
Early Diagnosis
1
2014
233
0.030
 Why?
Safety-net Providers
1
2014
109
0.030
 Why?
Infant, Premature
1
2017
541
0.030
 Why?
Adaptation, Ocular
1
2012
4
0.030
 Why?
Dark Adaptation
1
2012
14
0.030
 Why?
Rats, Mutant Strains
1
2012
24
0.030
 Why?
Child, Preschool
1
2007
10456
0.020
 Why?
Sclerostomy
1
2012
4
0.020
 Why?
Hypoglycemic Agents
1
2021
1219
0.020
 Why?
Cytomegalovirus
1
2013
154
0.020
 Why?
Mothers
1
2018
730
0.020
 Why?
Cell Count
1
2012
311
0.020
 Why?
Drug Implants
1
2012
82
0.020
 Why?
Bruch Membrane
1
2011
6
0.020
 Why?
Gold
1
2012
118
0.020
 Why?
Swine
1
2014
760
0.020
 Why?
Polyglycolic Acid
1
2011
39
0.020
 Why?
Miniaturization
1
2011
23
0.020
 Why?
Administration, Oral
1
2013
785
0.020
 Why?
Drug Stability
1
2011
159
0.020
 Why?
Delayed-Action Preparations
1
2011
172
0.020
 Why?
Chromatography, Gel
1
2010
126
0.020
 Why?
Immunoglobulin Light Chains
1
2010
40
0.020
 Why?
Immunoglobulin Heavy Chains
1
2010
80
0.020
 Why?
Fluorescein
1
2010
24
0.020
 Why?
Comorbidity
1
2015
1544
0.020
 Why?
Molecular Weight
1
2010
328
0.020
 Why?
Aptamers, Nucleotide
1
2010
77
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2010
327
0.020
 Why?
Microfluidic Analytical Techniques
1
2010
72
0.020
 Why?
Particle Size
1
2011
352
0.020
 Why?
Lactic Acid
1
2011
298
0.020
 Why?
Reference Values
1
2010
793
0.020
 Why?
Poverty Areas
1
2008
35
0.020
 Why?
Community Health Centers
1
2008
57
0.020
 Why?
Fluorescent Dyes
1
2010
312
0.020
 Why?
Optic Nerve Diseases
1
2008
34
0.020
 Why?
Kaplan-Meier Estimate
1
2010
851
0.020
 Why?
Models, Biological
1
2015
1722
0.020
 Why?
Kidney Transplantation
1
2013
671
0.020
 Why?
Pilot Projects
1
2012
1584
0.020
 Why?
Imaging, Three-Dimensional
1
2010
529
0.020
 Why?
Polyethylene Glycols
1
2011
587
0.020
 Why?
Pedigree
1
2007
486
0.020
 Why?
Image Processing, Computer-Assisted
1
2010
742
0.020
 Why?
Infusions, Intravenous
1
2006
399
0.020
 Why?
Anti-Bacterial Agents
1
2015
1702
0.010
 Why?
Adrenal Cortex Hormones
1
2008
522
0.010
 Why?
Severity of Illness Index
1
2011
2737
0.010
 Why?
Mass Screening
1
2008
1149
0.010
 Why?
Tomography, X-Ray Computed
1
2010
2515
0.010
 Why?
Risk Assessment
1
2008
3233
0.010
 Why?
Aging
1
2008
1774
0.010
 Why?
Diabetes Mellitus, Type 2
1
2012
2439
0.010
 Why?
Mutation
1
2007
3710
0.010
 Why?
Child
1
2012
20773
0.010
 Why?
Mandava's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (373) concept(s)
_
Co-Authors Expand Description
See all (49) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)